Ristia Bintang Mahkotasejati Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Ristia Bintang Mahkotasejati Tbk. trades at Rp66 (market cap 180.62B, 105.08M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 64.7× Ristia Bintang Mahkotasejati Tbk.'s market cap, and Ristia Bintang Mahkotasejati Tbk. is more actively traded (105.08M versus 429.7K). Which is the better fit depends on your goals.
| RBMS | TSPC | |
|---|---|---|
Market Cap | 180.62B | 11.68T |
Volume | 105.08M | 429.7K |
Lot | 1.05M | 4.3K |
Turnover | 7.02B | 1.11B |
Average Price | 66.78 | 2,591.65 |
Value | 7.02B | 1.11B |
Indicative Equilibrium Price | 66 | 2,580 |
Indicative Equilibrium Volume | 8.81K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.
Read more on RBMS →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →